<!doctype html>
<html lang="en">
  <head>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <title>TwinBridge | Home</title>
    <link rel="stylesheet" href="assets/style.css" />
  </head>
  <body>
    <nav class="nav">
      <div class="container nav-inner">
        <a class="brand" href="index.html">TwinBridge</a>
        <div class="nav-links">
          <a href="index.html">Home</a>
          <a href="product.html">Product</a>
          <a href="safeguards.html">Safeguards</a>
          <a href="disease-focus.html">Disease focus</a>
          <a href="evidence-pack.html">Evidence pack</a>
          <a href="contact.html">Contact</a>
        </div>
      </div>
    </nav>

    <header class="hero">
      <div class="container">
        <span class="tag">Research lab inspired</span>
        <h1>TwinBridge</h1>
        <p>Digital-twin synthetic control arms with public-health safeguards for decision-ready Phase II/III evidence.</p>
        <p>
          TwinBridge builds digital-twin models that support synthetic control arms and prognosis in neurodegenerative disease,
          while explicitly quantifying when results are reliable under shift, bias, and uncertainty.
        </p>
      </div>
    </header>

    <section class="section">
      <div class="container">
        <h2>What we do</h2>
        <div class="grid grid-3">
          <div class="card">
            <h3>Natural-history twins</h3>
            <p>Trajectory modeling and time-to-event endpoints in neurodegenerative disease.</p>
          </div>
          <div class="card">
            <h3>Synthetic controls</h3>
            <p>Augment or partially replace placebo arms when acceptability gates are met.</p>
          </div>
          <div class="card">
            <h3>Decision-readiness safeguards</h3>
            <p>Overlap/positivity, calibration/fidelity, and causal plausibility checks.</p>
          </div>
        </div>
      </div>
    </section>

    <section class="section">
      <div class="container">
        <h2>Integrity</h2>
        <div class="card integrity">
          <ul class="list">
            <li>Not universal control-arm replacement.</li>
            <li>Not portability without passing predefined gates.</li>
            <li>Not a clinical decision tool for individual patient care.</li>
          </ul>
        </div>
      </div>
    </section>

    <section class="section">
      <div class="container">
        <h2>Why it matters</h2>
        <p>
          When trials are small and endpoints are hard to measure, the risk is not only bias—it is overconfidence. Our focus is
          decision readiness: clear conditions for when evidence is strong enough to act, and when it is not.
        </p>
      </div>
    </section>

    <section class="section">
      <div class="container">
        <h2>Mission</h2>
        <p>
          TwinBridge focuses on epi-grade validity and decision readiness for neurodegenerative trials. We pair with pharma
          teams, hospitals, and natural history data companies to develop drug-specific solutions.
        </p>
      </div>
    </section>

    <footer class="footer">
      <div class="container">
        <span>TwinBridge</span> — decision-ready evidence for neurodegenerative trials.
      </div>
    </footer>

    <script src="assets/app.js"></script>
  </body>
</html>
